Cargando…
Full validation of therapeutic antibody sequences by middle-up mass measurements and middle-down protein sequencing
The regulatory bodies request full sequence data assessment both for innovator and biosimilar monoclonal antibodies (mAbs). Full sequence coverage is typically used to verify the integrity of the analytical data obtained following the combination of multiple LC-MS/MS datasets from orthogonal proteas...
Autores principales: | Resemann, Anja, Jabs, Wolfgang, Wiechmann, Anja, Wagner, Elsa, Colas, Olivier, Evers, Waltraud, Belau, Eckhard, Vorwerg, Lars, Evans, Catherine, Beck, Alain, Suckau, Detlev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966597/ https://www.ncbi.nlm.nih.gov/pubmed/26760197 http://dx.doi.org/10.1080/19420862.2015.1128607 |
Ejemplares similares
-
Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques
por: Ayoub, Daniel, et al.
Publicado: (2013) -
Top-Down Identification and Sequence Analysis of Small
Membrane Proteins Using MALDI-MS/MS
por: Meier-Credo, Jakob, et al.
Publicado: (2022) -
Rapid, automated characterization of disulfide bond scrambling and IgG2 isoform determination
por: Resemann, Anja, et al.
Publicado: (2018) -
Structural and Functional Characterization of SARS-CoV-2
RBD Domains Produced in Mammalian Cells
por: Gstöttner, Christoph, et al.
Publicado: (2021) -
Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites
por: Möginger, Uwe, et al.
Publicado: (2016)